Outsourcing in Clinical Trials Handbook 2022

The go-to guide for professionals in the global clinical outsourcing space

31

December

  • Download
  • Complimentary
  • 2022 Handbook
  • Article Contributors
  • Sponsors
  • Contact Us
close

2022 Handbook

Agenda

Expand All

Article Contributors

Select a speaker to learn more

Back
DOUG CARY
President, Cary Pharmaceuticals

Dr. Cary's entire professional career has been in the pharmaceutical industry. He has extensive experience in injectable products research and development as well as Drug Development. An MBA degree has given him the background to be an effective leader in New Business Development. At Abbott he successfully championed the development of pre-mixed drugs, as well as the Add-Vantage Drug Delivery System. He also played a critical role in the identification and commercialization of PCA (patient controlled analgesia). He is a co-founder of a successful specialty pharmaceutical company, Cary Pharmaceuticals Inc. and is the sole inventor of US patent 6,197,827 titled, Nicotine Addiction Treatment.

Next speaker
Back
ROGER NOLAN
President, BioKier,

Roger has 30 years of management and drug development expertise from his leading roles in preclinical and clinical drug development programs, regulatory strategy and interactions, funding, and outsourcing to specialist service providers. With his experience in basic research, large and small pharma, and CRO settings he provides valuable insight into business and R&D operations for pharma/biotech companies. His specific therapeutic areas of expertise are in diabetes, oncology, gene therapy, and cardiovascular indications. He is currently President and Co-Founder at BioKier and was previously CEO at Plakous Therapeutics and Senior Scientist in Clinical Development at Cato Research. Roger received a PhD in Pharmacology and Biochemistry from Melbourne University and completed Postdoctoral fellowships at the National Institute of Environmental Health Sciences and at Burroughs Wellcome.

Next speaker
Back
KEVIN CRAWFORD
Head Of Clinical Operations, Tenax Therapeutics

Currently leading Clinical Operations at Tenax Therapeutics, Kevin M. Crawford is a 23-year clinical research veteran, having held leadership posts under such leading brands as GlaxoSmithKline (GSK), Johnson & Johnson, and United Therapeutics. A certified executive coach, contributing writer and vlogger as well, Kevin’s insights on a personal and professional mission, organizational leadership and life balance have garnered a growing cult following and demand as an executive consultant and speaker. With a Master’s degree in Biotechnology from the University of Maryland, he has published in the Journals of the American Thoracic Society and American College of Chest Physicians. Kevin lives in Raleigh, NC with his wife and three children, and when he is not “ON,” he enjoys playing soccer, kayaking, volunteering and having bad coffee with good friends

Next speaker
Back
RYAN TUBBS
Co-Founder, Clinical Research Innovation Hub, Microsoft Corporation

Co-Founder, Clinical Research Innovation Hub, Microsoft Corporation The Clinical Research Innovation Hub (CRIH) is the first industry focused internal startup in Microsoft. Innovation hubs are engines that allow Microsoft to focus on pressing industry problems by combining the speed, agility and autonomy of a startup with resources available to a large enterprise. CRIH analyzes problems deeply through interviews and experiments, then rapidly builds solutions alongside Microsoft customers and partners. Ryan is responsible for the operations of the innovation hub, for the management of the portfolio, and for creating the conditions for agile and open innovation. CRIH is enabling Microsoft and its partners to conceptualize, incubate, and ultimately deliver the technology innovations that will drive the adoption of new clinical research paradigms. Ryan has been with Microsoft for 12 years. Prior to his current role he served as a Chief Transformation Officer for the US subsidiary, responsible for designing and executing change management strategies for transforming sales, marketing, and services operations for the $33B business. Before joining Microsoft, Ryan was the CIO for the City of Chicago city council, responsible for implementing IT policies and data security protocols to protect the integrity of sensitive citizen and employee data. He partnered with Microsoft and implementation partners to modernize and transform dozens of legacy systems, enabling greater transparency in government and more citizen-centric applications. Ryan holds a Bachelor of Science in Chemical Engineering from North Carolina State University and a Master of Business Administration from Duke University (The Fuqua School of Business).

Next speaker
Back
BRIAN NUGENT
Sr. Director Clinical Operations And Compliance, GRAIL
Next speaker
Back
Michael Breen
Associate Director, Infectious Disease, GlobalData Healthcare

Michael Breen, PhD, is the Senior Director of Infectious Diseases and Oncology at GlobalData in Boston. He has over eight years of experience in market analysis, business intelligence, and providing strategic insight for the pharmaceutical industry. Prior to his current role, he was a Senior Analyst for Decision Resources Group, where he gained extensive experience writing in-depth reports and developing forecasts for a variety of indications, including rare and infectious diseases and vaccines. Michael has a BA in biology and biochemistry from Hunter College, and a PhD in biochemistry from Boston University School of Medicine.

Next speaker

Sponsors

Select a sponsor to learn more

Sponsors

Enquiry

Contact Us

ADVERTISING OPPORTUNITIES

Oliver Cole

Sponsorship Sales Executive – Healthcare

+44 (0) 20 4540 6936

ARTICLE CONTRIBUTION

Chloe Roberts

Director of Events- OCT Series

+44 (0) 2075090470

MARKETING ENQUIRIES

Katie Giorgadze

+44 (0)20 7936 6656

ADVERTISING OPPORTUNITIES

 

Oliver Cole

Sponsorship Sales Executive – Healthcare


+44 (0) 20 4540 6936

ARTICLE CONTRIBUTION ENQUIRIES

 

Chloe Roberts

Head of Healthcare


+44 (0) 20 7509 0470